Live
CSLFINANCE logoCSLFINANCEstock

CSL Finance Ltd

₹226.45
-0.04%
Open
₹228.95
High
₹229
Low
₹224.95
Volume
12.5K

Price chart

Daily close · downsampled 5-year history

2021-06-21 · ₹114.172026-06-18 · ₹224.15

Instrument details

MB Code
MBEQU1240
Type
stock
ISIN
INE718F01018
BSE
530067
Industry
Finance

Latest earnings

Q4FY26 declared

Quarter
Mar 2026
Revenue
68.8 Cr
Net profit
19.42 Cr
EPS
8.46
YoY revenue
+21.71%

Price returns

Historical performance

1 day
-1.02%
1 month
-0.38%
3 months
-10.63%
1 year
-31.73%
3 years
-17.85%
5 years
+102.54%

Technicals

Indicator consensus

Bullish
4
Neutral
8
Bearish
34
RSI 43.35(Neutral)

Corporate timeline

Price chart events · 1 year

Dividend
2025-09-12
{"amount":3}
News
2026-02-10
{"description":"CSL's shares fell to an 8-year low following the announcement of CEO Paul McKenzie's departure and disappointing earnings results, raising concerns about the company's future leadership and performance.","url":"https://www.msn.com/en-us/money/other/shares-of-australian-biotech-major-csl-plunge-to-8-year-low-after-ceo-departure-weak-earnings/ar-AA1W5IOJ?ocid=BingNewsVerp","sentiment":"Negative","domain":"CNBC on MSN"}
News
2025-08-19
{"description":"CSL, Australia's fourth-largest company, plans to spin off its vaccine division and cut up to 3,000 jobs, leading to a significant drop in shares.","url":"https://www.msn.com/en-us/money/markets/csl-to-axe-up-to-3000-employees-and-spin-off-vaccine-arm-shares-tumble/ar-AA1KO47k?ocid=BingNewsVerp","sentiment":"Negative","domain":"Reuters on MSN"}
News
2025-08-18
{"description":"CSL plans to cut up to 15% of its staff and spin off its Seqirus business in a restructuring effort costing up to $770 million.","url":"https://www.morningstar.com/news/dow-jones/202508188264/csl-to-cut-up-to-15-of-staff-in-770-million-restructure","sentiment":"Negative","domain":"Morningstar"}